Marine Capt. Derek Herrera, who was paralyzed by a sniper's bullet two years ago in southern Afghanistan, is walking again thanks to a set of robotic leg braces known as the ReWalk system. Herrera is the first in the United States to own the device ... Miami Herald, 1 hour ago
Manufacturers of Simply Slick Comment on Recent FDA Changes and World Health Organization Findings on Personal Lubricants. Is Safe Sex Safe?
Recent research by the World Health Organization (WHO)  suggests that many conventional personal lubricants may actually be putting users at higher risk of contracting sexually transmitted diseases. These findings have triggered a new round of ...Digital Journal, 4 hours ago
Federal regulators gave the green light to a once-a-day opioid pain-relief pill that is up to 24 times more powerful than a single Vicodin but is designed to thwart the immediate release of its full — and potentially lethal — payload. The U.S.Los Angeles Times, 19 hours ago FDA Clears Hydrocodone With Abuse-Deterrent Properties American Journal of Public Health, 21 hours ago FDA Approves Purdue's Abuse-Deterrent Pain Pill RTTNews.com, 23 hours ago FDA: New Opioid a Little Harder To Abuse Pharmacy Practice News, 1 hour ago
More from: InteliHealth, CNBC...and 42 other sources
Reuters Health Information By Reuters Staff November21,2014 PARIS (Reuters) - Sanofi and its U.S. partner Regeneron said on Thursday the U.S. Food and Drug Administration had designated their dupilumab drug as "breakthrough therapy" in the ...Medscape, 7 hours ago Atopic Dermatitis Treatment Placed on Accelerated FDA Approval Track Pharmacy Times, 5 hours ago Sanofi SA (SNY), Regeneron Pharmaceuticals (REGN) Eczema Drug Gets FDA Breakthrough Therapy Designation Bidness Etc, 1 day ago Regeneron, Sanofi's Dupilumab Gets Breakthrough Therapy Designation From FDA RTTNews.com, 1 day ago
News Editor The FDA accepts Cerus Corp.'s (NASDAQ:CERS) IDE supplement to make its Intercept Blood System for plasma available to treat convalescent plasma collected from Ebola survivors for passive immune therapy. Transfusion of blood or plasma ...Seeking Alpha, 6 hours ago Immunomedics (IMMU) Receives FDA Oprhan Drug Designation for Veltuzumab as Pemphigus Treatment Financial Content, 7 hours ago FDA Accepts IDE Supplement for INTERCEPT Blood System Treatment of Ebola Convalescent Plasma A.M. Best, 7 hours ago ChemoCentryx (CCXI) Reports CCX168 Granted Ophan Drug Designation by U.S. FDA Wall Street Business Network, 23 hours ago
More from: Town Hall, Stock Nod...and 39 other sources
Johnson & Johnson 's ( JNJ ) Janssen Research & Development is seeking FDA approval for a three-month formulation of its long-acting atypical antipsychotic, paliperidone palmitate, for the treatment of adults suffering from schizophrenia. A ...Yahoo! Finance, 23 hours ago Janssen seeks FDA approval for its antipsychotic drug to treat schizophrenia Pharmaceutical Technology, 1 day ago FDA Accepts Submission for First Long-Acting Schizophrenia Treatment Pharmacy Times, 1 day ago Janssen Submits New Drug Application to U.S. FDA for Three-Month Paliperidone Palmitate PipelineReview, 2 days ago
Ranbaxy Laboratories Ltd has sued US Food and Drug Administration (FDA) for revoking approvals granted to the firm to launch copies of two drugs including AstraZeneca Plc's heartburn pill Nexium, according to reports. Top News Aurobindo Pharma's director ...India Infoline, 13 hours ago US court overturns Ranbaxy's bid to block launch of rival generic drugs Business Standard, 1 day ago US judge denies Ranbaxy's request to block FDA approval of Nexium, Valcyte generics FirstWord Pharma, 1 day ago Ranbaxy sues US FDA on Nexium and Valcyte PharmaBiz, 2 days ago
Avaxia Biologics Receives FDA Orphan Drug Designation for AVX-470 for the Treatment of Pediatric Ulcerative Colitis
Avaxia Biologics, Inc. , a clinical-stage biopharmaceutical company developing gut-targeted antibody therapeutics for gastrointestinal diseases, announced today that the US Food and Drug Administration (FDA) granted ...CEOWorld Magazine, 4 hours ago Bio Blast Pharma Ltd receives orphan drug designation from U.S. FDA for Cabaletta for the Treatment of Spinocerebellar Ataxia Type 3 Reuters UK, 1 day ago BerGenBio's BGB324 gets orphan-drug designation from FDA for AML treatment News-Medical.Net, 2 days ago Juno's Leukemia T Cell Therapy Granted Orphan Drug Designation By FDA PharmaAsia, 2 days ago
By Estel Grace Masangkay Roche announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its cobas Strep A test for the detection of group A streptococcus bacterial (Strep A) DNA. The cobas Strep A uses ...Laboratory Network, 3 hours ago Roche nabs FDA clearance for quick strep test Fierce BioMarkers, 2 days ago
News Editor November 26 is the PDUFA date for the FDA's decision on Avanir Pharmaceuticals' (AVNR +0.9%) NDA for AVP-825, its investigational drug-device combination for the acute treatment of migraines. Approval is unlikely, though. Earlier this ...Seeking Alpha, 5 hours ago
on your WebpageAdd Widget >Get your members hooked!